Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Bayesian mixed-effects location and scale models for multivariate longitudinal outcomes: an application to ecological momentary assessment data.
Defining hierarchical protein interaction networks from spectral analysis of bacterial proteomes.
Hidden Port Site Incisions for Robotic Foregut and Hepatopancreatobiliary Operations: A Cosmetically Superior Approach.
High-throughput assays for the development of SIRT5-specific inhibitors
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood Adv. 2023 03 14; 7(5):768-777.
View in:
PubMed
subject areas
Humans
Lymphocytes
Multiple Myeloma
Neurotoxicity Syndromes
authors with profiles
Andrzej Jakubowiak
Michael Bishop